These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12759418)

  • 21. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
    Hussain S; Delovitch TL
    J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A defect in lineage fate decision during fetal thymic invariant NKT cell development may regulate susceptibility to type 1 diabetes.
    Wagner MJ; Hussain S; Mehan M; Verdi JM; Delovitch TL
    J Immunol; 2005 Jun; 174(11):6764-71. PubMed ID: 15905517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Another view of T cell antigen recognition: cooperative engagement of glycolipid antigens by Va14Ja18 natural T(iNKT) cell receptor [corrected].
    Stanic AK; Shashidharamurthy R; Bezbradica JS; Matsuki N; Yoshimura Y; Miyake S; Choi EY; Schell TD; Van Kaer L; Tevethia SS; Roopenian DC; Yamamura T; Joyce S
    J Immunol; 2003 Nov; 171(9):4539-51. PubMed ID: 14568927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection against diabetes and improved NK/NKT cell performance in NOD.NK1.1 mice congenic at the NK complex.
    Carnaud C; Gombert J; Donnars O; Garchon H; Herbelin A
    J Immunol; 2001 Feb; 166(4):2404-11. PubMed ID: 11160299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular genetic analysis of the Idd4 locus implicates the IFN response in type 1 diabetes susceptibility in nonobese diabetic mice.
    Ivakine EA; Gulban OM; Mortin-Toth SM; Wankiewicz E; Scott C; Spurrell D; Canty A; Danska JS
    J Immunol; 2006 Mar; 176(5):2976-90. PubMed ID: 16493056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic and functional analysis of the Nkt1 locus using congenic NOD mice: improved Valpha14-NKT cell performance but failure to protect against type 1 diabetes.
    Rocha-Campos AC; Melki R; Zhu R; Deruytter N; Damotte D; Dy M; Herbelin A; Garchon HJ
    Diabetes; 2006 Apr; 55(4):1163-70. PubMed ID: 16567543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel mouse model for invariant NKT cell study.
    Wakao H; Kawamoto H; Sakata S; Inoue K; Ogura A; Wakao R; Oda A; Fujita H
    J Immunol; 2007 Sep; 179(6):3888-95. PubMed ID: 17785826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen Therapy Delays Autoimmune Diabetes and Promotes the Protective Efficiency of Natural Killer T-Cell Activation in Female Nonobese Diabetic Mice.
    Gourdy P; Bourgeois EA; Levescot A; Pham L; Riant E; Ahui ML; Damotte D; Gombert JM; Bayard F; Ohlsson C; Arnal JF; Herbelin A
    Endocrinology; 2016 Jan; 157(1):258-67. PubMed ID: 26485613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance alleles.
    Martinez X; Kreuwel HT; Redmond WL; Trenney R; Hunter K; Rosen H; Sarvetnick N; Wicker LS; Sherman LA
    J Immunol; 2005 Aug; 175(3):1677-85. PubMed ID: 16034108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic disassociation of autoimmunity and resistance to costimulation blockade-induced transplantation tolerance in nonobese diabetic mice.
    Pearson T; Markees TG; Serreze DV; Pierce MA; Marron MP; Wicker LS; Peterson LB; Shultz LD; Mordes JP; Rossini AA; Greiner DL
    J Immunol; 2003 Jul; 171(1):185-95. PubMed ID: 12816997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.
    Trembleau S; Penna G; Gregori S; Giarratana N; Adorini L
    J Immunol; 2003 Jun; 170(11):5491-501. PubMed ID: 12759426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Through regulation of TCR expression levels, an Idd7 region gene(s) interactively contributes to the impaired thymic deletion of autoreactive diabetogenic CD8+ T cells in nonobese diabetic mice.
    Serreze DV; Choisy-Rossi CM; Grier AE; Holl TM; Chapman HD; Gahagan JR; Osborne MA; Zhang W; King BL; Brown A; Roopenian D; Marron MP
    J Immunol; 2008 Mar; 180(5):3250-9. PubMed ID: 18292549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.
    Sharif S; Arreaza GA; Zucker P; Mi QS; Sondhi J; Naidenko OV; Kronenberg M; Koezuka Y; Delovitch TL; Gombert JM; Leite-De-Moraes M; Gouarin C; Zhu R; Hameg A; Nakayama T; Taniguchi M; Lepault F; Lehuen A; Bach JF; Herbelin A
    Nat Med; 2001 Sep; 7(9):1057-62. PubMed ID: 11533711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surprisingly minor influence of TRAV11 (Valpha14) polymorphism on NK T-receptor mCD1/alpha-galactosylceramide binding kinetics.
    Sim BC; Holmberg K; Sidobre S; Naidenko O; Niederberger N; Marine SD; Kronenberg M; Gascoigne NR
    Immunogenetics; 2003 Mar; 54(12):874-83. PubMed ID: 12671739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of regulatory invariant CD1d-restricted natural killer T-cells in protection against type 1 diabetes.
    Hussain S; Wagner M; Ly D; Delovitch TL
    Immunol Res; 2005; 31(3):177-88. PubMed ID: 15888910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of a non-NK complex region of chromosome 6 on CD4+ invariant NK T cell homeostasis.
    Vallois D; Gagnerault MC; Avner P; Rogner UC; Boitard C; Benlagha K; Herbelin A; Lepault F
    J Immunol; 2008 Aug; 181(3):1753-9. PubMed ID: 18641312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invariant natural killer T-cell control of type 1 diabetes: a dendritic cell genetic decision of a silver bullet or Russian roulette.
    Driver JP; Scheuplein F; Chen YG; Grier AE; Wilson SB; Serreze DV
    Diabetes; 2010 Feb; 59(2):423-32. PubMed ID: 19903740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cell-type specific CD1d expression program modulates invariant NKT cell development and function.
    Zimmer MI; Colmone A; Felio K; Xu H; Ma A; Wang CR
    J Immunol; 2006 Feb; 176(3):1421-30. PubMed ID: 16424169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.